Similar results regarding the relationship between CAT and NAFLD were obtained by Perlemuter et al. Only 16 patients with NAFLD diagnosed on the basis of ALT activity, BMI values and a hepatorenal difference in echo intensities participated in this study and were compared to 16 individuals without NAFLD. The gene discussed is GPT; the disease is metabolic dysfunction-associated steatotic liver disease.